IMMUNOGENIC CORONAVIRUS FUSION PROTEINS AND RELATED METHODS
IMMUNOGENIC CORONAVIRUS FUSION PROTEINS AND RELATED METHODS
Researchers at Stanford have developed fusion proteins as a novel vaccine strategy for SARS-CoV2.
As the causative force of the COVID-19 pandemic, SARS-CoV2 caused massive sustained morbidity, mortality, and societal disruption worldwide. Though COVID-19 has largely transitioned from...
Published: 12/3/2024
|
Inventor(s): Peter Kim, Natalia Friedland, Mrinmoy Sanyal, Payton Weidenbacher
Keywords(s): Coronavirus, COVID, COVID-19, Infectious Disease, Vaccine
Category(s): Technology Classifications > Biology
|